DORDAVIPRONE 
| DORDAVIPRONE | ANTINEOPLASTIC PROTEASE ACTIVATOR TREATMENT OF PATIENTS WITH DIFFUSE MIDLINE GLIOMA | ORAL | Cmax 7.2 MICROMOLAR Tmax 1.4 HOUR VD 450 LITER PPB 96 PERCENT Cl 27 LITER / HOUR HT 11 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | MITOCHONDRIAL CASEINOLYTIC PROTEASE P (CLPP) DOPAMINE D2 RECEPTOR | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |